Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Henninger

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Annals of Neurology|April 1, 1995
Decreased CD3-mediated interferon-gamma production in relapsing-remitting multiple sclerosisS A Brod, M Khan, J Bright, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 1997
Ingested IFN-alpha has biological effects in humans with relapsing-remitting multiple sclerosisS A Brod, R H Kerman, L D Nelson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 26, 2023
Long-term outcomes of COVID-19 survivors with hospital AKI: association with time to recovery from AKIJustin Y Lu, Montek S Boparai, Caroline Shi, et al.
Heliyon|April 13, 2023
Characteristics of COVID-19 patients with multiorgan injury across the pandemic in a large academic health system in the Bronx, New YorkJustin Y Lu, Alexandra Buczek, Roman Fleysher, et al.
Diabetes, Obesity & Metabolism|May 31, 2023
Incidence, characteristics, risk factors and outcomes of diabetic ketoacidosis in COVID-19 patients: Comparison with influenza and pre-pandemic dataKevin Dell'Aquila, Jeylin Lee, Stephen H Wang, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Annals of Neurology|April 1, 1995
Decreased CD3-mediated interferon-gamma production in relapsing-remitting multiple sclerosisS A Brod, M Khan, J Bright, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 1997
Ingested IFN-alpha has biological effects in humans with relapsing-remitting multiple sclerosisS A Brod, R H Kerman, L D Nelson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 26, 2023
Long-term outcomes of COVID-19 survivors with hospital AKI: association with time to recovery from AKIJustin Y Lu, Montek S Boparai, Caroline Shi, et al.
Heliyon|April 13, 2023
Characteristics of COVID-19 patients with multiorgan injury across the pandemic in a large academic health system in the Bronx, New YorkJustin Y Lu, Alexandra Buczek, Roman Fleysher, et al.
Diabetes, Obesity & Metabolism|May 31, 2023
Incidence, characteristics, risk factors and outcomes of diabetic ketoacidosis in COVID-19 patients: Comparison with influenza and pre-pandemic dataKevin Dell'Aquila, Jeylin Lee, Stephen H Wang, et al.
Pageof 3